Perspective Therapeutics (CATX) Return on Capital Employed (2011 - 2026)

Perspective Therapeutics (CATX) has 15 years of Return on Capital Employed data on file, last reported at 35.96% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 504.0% year-over-year to 35.96%; the trailing twelve-month figure through Mar 2026 stood at 35.96% (down 504.0% YoY), and the FY2025 full-year result was 41.24%, up 391.0% from the prior year.
• Return on Capital Employed rose to 35.96% in Q1 2026, from 41.26% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6.09% in Q1 2022 to a low of 46.24% in Q4 2023.
• A 5-year average of 28.13% and a median of 30.91% in 2025 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed slumped 2673 bps in 2022 and jumped 2012 bps in 2024, its largest moves.
• Tracing CATX's Return on Capital Employed over 5 years: stood at 31.77% in 2022, then plunged by 46 bps to 46.24% in 2023, then surged by 44 bps to 26.12% in 2024, then tumbled by 58 bps to 41.26% in 2025, then increased by 13 bps to 35.96% in 2026.
• Business Quant data shows CATX's Return on Capital Employed at 35.96% in Q1 2026, 41.26% in Q4 2025, and 39.26% in Q3 2025.